Back
Pliant Therapeutics Stock Price Chart
Sponsored
PLRX
Sponsored
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
PLRX
Pliant Therapeutics
Last Price:
12.85
Seasonality Move:
18.67%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
Pliant Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 13.16 | Sell |
20-day SMA: | 14.05 | Sell |
50-day SMA: | 13.02 | Sell |
200-day SMA: | 13.4 | Sell |
8-day EMA: | 13.14 | Sell |
20-day EMA: | 13.59 | Sell |
50-day EMA: | 13.37 | Sell |
200-day EMA: | 13.78 | Sell |
Pliant Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.18 | Sell |
Relative Strength Index (14 RSI): | 41.48 | Sell |
Chaikin Money Flow: | 461837 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (13.28 - 15.1) | Sell |
Bollinger Bands (100): | (11.61 - 14.11) | Sell |
Pliant Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Pliant Therapeutics Stock
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 12.73 while PLRX 8-day simple moving average is 13.16, which is a Sell signal.
- The stock price of PLRX is 12.73 while Pliant Therapeutics 20-day SMA is 14.05, which makes it a Sell.
- Pliant Therapeutics 50-day simple moving average is 13.02 while PLRX share price is 12.73, making it a Sell technically.
- PLRX stock price is 12.73 and Pliant Therapeutics 200-day simple moving average is 13.40, creating a Sell signal.
PLRX Technical Analysis vs Fundamental Analysis
Sell
39
Pliant Therapeutics (PLRX)
is a Sell
Is Pliant Therapeutics a Buy or a Sell?
-
Pliant Therapeutics stock is rated a Sell
The current Pliant Therapeutics [PLRX] share price is $12.73. The Score for PLRX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Pliant Therapeutics Stock Info
Market Cap:
774.67M
Price in USD:
12.73
Share Volume:
480.31K
Pliant Therapeutics 52-Week Range
52-Week High:
19.62
52-Week Low:
10.22
Sell
39
Pliant Therapeutics (PLRX)
is a Sell
Pliant Therapeutics Share Price Forecast
-
What is the Pliant Therapeutics stock price today?
The Pliant Therapeutics stock price is 12.73 USD today. -
Will PLRX stock go up or go down?
Pliant Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Pliant Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Pliant Therapeutics is overvalued.
Is Pliant Therapeutics Stock a Buy?
- Pliant Therapeutics share price is 12.73 while PLRX 8-day exponential moving average is 13.14, which is a Sell signal.
- The stock price of PLRX is 12.73 while Pliant Therapeutics 20-day EMA is 13.59, which makes it a Sell.
- Pliant Therapeutics 50-day exponential moving average is 13.37 while PLRX share price is 12.73, making it a Sell technically.
- PLRX stock price is 12.73 and Pliant Therapeutics 200-day simple moving average is 13.78, creating a Sell signal.
Fundamental Analysis of Pliant Therapeutics
Is Pliant Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.74 per share, and a decrease next year of $0.33 per share.
Technical Analysis of Pliant Therapeutics
Should I short Pliant Therapeutics stock?
- PLRX Moving Average Covergence Divergence (MACD) indicator is -0.18, suggesting Pliant Therapeutics is a Sell
- Pliant Therapeutics Relative Strength Index (RSI) is 41.48, which suggest Pliant Therapeutics is oversold
- The Bollinger Bands (25) for Pliant Therapeutics is (13.28 - 15.1), which suggest Pliant Therapeutics is a Sell
- The Bollinger Bands (100) for Pliant Therapeutics is (11.61 - 14.11), which suggest Pliant Therapeutics is a Sell
* Pliant Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.